pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,063 catalysts · 5,063 phase readout · 2,312 8k filing · 316 pdufa · 273 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 16 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: device recall×type: phase readout×clear all
type
  • phase readout5,063
  • 8k filing2,312
  • pdufa316
  • earnings273
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT06967415: Comparison of Pain, Sensitisation, Function and Quality of Life According to Stenosis Degree in Chronic Neck Pain

    Sponsor: Izmir Democracy University. Phase: NA. Conditions: Central Sensitisation, Cervical Spine Stenosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07054515: A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

    Sponsor: Azafaros B.V.. Phase: PHASE3. Conditions: Niemann-Pick Type C Disease, GM1 Gangliosidosis, GM2 Gangliosidosis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06924515: The Application Value of Intercostal Suturing in Preventing Postoperative Thoracoscopic Lung Resection Chest Wall Pulmonary Hernia

    Sponsor: Mingjian Ge. Phase: NA. Conditions: VATS, Lung Hernia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06159335: 18F-FLUC PET/MR in Patients With Brain Mets

    Sponsor: University of Wisconsin, Madison. Phase: PHASE3. Conditions: Brain Metastasis, Radiation Therapy, Immunotherapy, Active

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04197908: EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study.

    Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Acute Cholecystitis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07210125: Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

    Sponsor: Kelley-Ross & Associates, Inc.. Phase: PHASE4. Conditions: HIV

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07423325: Validation of Skin Instrumentation to Detect Ceramide-Driven Lipid Replenishment - Assessing Skin Glow, Hydration, Trans Epidermal Water Loss, Skin Surface Assessment, Sebum and Least-Reflection Factor.

    Sponsor: NovoBliss Research Pvt Ltd. Phase: NA. Conditions: Dry and Sensitive Skin

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05274425: A 24-week rPMS Study in Real-world Setting for Enerzair

    Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Asthma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05266976: Mode of Exercise and Bone Biomarkers in Older Veterans

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Aging, Musculoskeletal Diseases, Osteoporosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06719076: IMPACT OF DIABETES HEALTHCARE PROGRAM ON GLYCEMIC CONTROL, SELF-EFFICACY AND DIABETES KNOWLEDGE AMONG TYPE-II DIABETICS IN ISLAMABAD PAKISTAN

    Sponsor: Health Services Academy, Islamabad, Pakistan. Phase: NA. Conditions: HbA1c, Self-Efficacy, Diabetes Knowledge

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07228117: GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

    Sponsor: Medtronic MiniMed, Inc.. Phase: NA. Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07485517: Deep Versus Moderate Neuromuscular Blocking

    Sponsor: Menoufia University. Phase: NA. Conditions: Change in Serum Levels of the Estimated Inflammatory Cytokines, Total Dose of IO Fentanyl, PO Morphine, Surgeons' Rating, Pain Scores

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07373717: Consistency of Fluid Tolerance Evaluation Methods and Their Correlation With Clinical Outcomes in Patients With Shock

    Sponsor: Southeast University, China. Phase: . Conditions: Shock

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06695117: Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

    Sponsor: Sanofi. Phase: PHASE1. Conditions: COVID-19 Immunization, Influenza Immunization

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04386317: Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

    Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05245617: Observational Study on JuniOrtho Plating System for Deformities and Fractures Treatment in Lower Limb

    Sponsor: Orthofix s.r.l.. Phase: . Conditions: Deformity, Defect, Congenital, Trauma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06691217: Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

    Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Vascular Inflammation, ASCVD, ASCVD Management

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04587440: Is the Dynamic of the Pelvic Bone Altered After a Total Hip Replacement ?

    Sponsor: University Hospital, Brest. Phase: NA. Conditions: Coxarthrosis; Primary, Coxarthrosis; Secondary

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07290140: Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

    Sponsor: Airiver Medical, Inc.. Phase: NA. Conditions: Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05861089: Rest PETCO2 as a Predictor of Post-operative Complications

    Sponsor: St. Anne's University Hospital Brno, Czech Republic. Phase: . Conditions: Post-Op Complication

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06163989: Protecting the Eyes of Gamers With Lubricating Eyedrops

    Sponsor: Aston University. Phase: NA. Conditions: Dry Eye Syndromes, Computer Vision Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07428889: Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement

    Sponsor: Shaklee Corporation. Phase: NA. Conditions: Healthy Adult

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00801489: Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, de Novo Myelodysplastic Syndrome, High Risk Myelodysplastic Syndrome, Inv(16), Myelodysplastic Syndrome With Excess Blasts, t(16;16), t(8;21), Untreated Adult Acute Myeloid Leukemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06005168: Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis

    Sponsor: University of Michigan. Phase: PHASE4. Conditions: Surgical Prophylaxis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05277168: A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

    Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07506668: RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

    Sponsor: Affiliated Hospital of Nantong University. Phase: PHASE1. Conditions: Relapsed/Refractory B-cell Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03896568: MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Malignant Glioma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07472959: Effect of Intraoperative Morphine on Postoperative Pain After CABG

    Sponsor: Istanbul University - Cerrahpasa. Phase: PHASE4. Conditions: Cardiac Surgery Patient, Postoperative Pain, Pain After Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07151859: Clinical Investigation on a Polynucleotide-based Device Used to Improve Skin Hydration

    Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Aesthetic Improvement of the Skin, Skin Hydration in Healthy Volunteers, Skin Elasticity, Skin Turgor, Subject Satisfaction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07649759: Mindfulness-Based Nutrition Group Therapy as an Adjunct to GLP-1 Treatment of Obesity

    Sponsor: Bern University of Applied Sciences. Phase: NA. Conditions: Obesity & Overweight, Emotional Eating Behaviour, Mindful Eating Intervention

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07434362: Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy

    Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: NA. Conditions: Diabetic Retinopathy, Diabetes Mellitus, Retinal Microvascular Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07180862: A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

    Sponsor: Bio-Thera Solutions. Phase: PHASE1. Conditions: Carcinoma, Non-Small-Cell Lung

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06477146: Milk Thistle Clinical Trial in Pediatric NAFLD

    Sponsor: University Hospitals Cleveland Medical Center. Phase: PHASE2. Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01802346: Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer

    Sponsor: University of Southern California. Phase: NA. Conditions: Breast Cancer, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07662603: Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

    Sponsor: Cairo University. Phase: NA. Conditions: Behcet Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07657988: Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)

    Sponsor: Avant Health LLC. Phase: . Conditions: Actinic Keratosis (AK)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07370688: Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation

    Sponsor: Erasmus Medical Center. Phase: PHASE4. Conditions: Aortic Valve Stenosis, Iron Deficiency, TAVI(Transcatheter Aortic Valve Implantation), Cardiovascular Diseases

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07500961: Novel Bone Substitute (ALBO-OS) in Patients With Periodontal Disease or Who Need Alveolar Preservation

    Sponsor: Albos d.o.o. Beograd. Phase: NA. Conditions: Periodontitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07340242: Dentoskeletal Effects of 3D-Printed Fixed Twin Block Versus MARA Appliances in Management of Skeletal Class II

    Sponsor: Mansoura University. Phase: NA. Conditions: Class II Malocclusion, Mandibular Deficiency

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06382142: A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)

    Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Triple-Negative Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07564986: Relationship Between Serum Resistin Levels and Reduction in Visceral Fat in Patients Undergoing Sleeve Gastrectomy Due to Morbid Obesity

    Sponsor: Sercan YUKSEL, MD. Phase: . Conditions: Morbid Obesity Requiring Bariatric Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01538342: Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Psoriasis, Atopic Dermatitis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07619586: Lumbar Spinal Manipulation in Stroke

    Sponsor: Bitlis Eren University. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06725173: Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

    Sponsor: University of Washington. Phase: . Conditions: Retinoblastoma Bilateral, Retinoblastoma Unilateral, Retinoblastoma, Extraocular, Retinoblastoma, Recurrent, Retinoblastoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06363773: A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.

    Sponsor: Elsan. Phase: NA. Conditions: Metastatic Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06431373: A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

    Sponsor: Priovant Therapeutics, Inc.. Phase: PHASE3. Conditions: Uveitis, Posterior, Uveitis, Intermediate, Uveitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07031869: The Swedish Hockey League Hand and Wrist Injury Tracking Trial

    Sponsor: Dalarna County Council, Sweden. Phase: . Conditions: Register, Injuries, Athletes, Hand Injuries, Wrist Injuries, Prevention

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07584369: Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study

    Sponsor: University of California, San Francisco. Phase: PHASE4. Conditions: HIV -1 Infection, Methamphetamine Use

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04677569: Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

    Sponsor: Insmed Incorporated. Phase: PHASE3. Conditions: Mycobacterium Infections, Nontuberculous

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04049383: CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL

    Sponsor: Medical College of Wisconsin. Phase: PHASE1. Conditions: Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia Not Having Achieved Remission, Acute Lymphoblastic Leukemia, Pediatric, Acute Lymphoblastic Leukemia

    full page →ctgov ↗
    ← prev
    page 97 of 102
    next →